2000 Clinical Trials Safety 
Cannabis Law Report
JULY 19, 2021
There is an urgent need for objective, scientifically sound and robust clinical trials to support medicinal cannabis and psychedelics (psilocybin, MDMA, LSD, Ketamine). Extensive early phase experience with appropriate safety oversight and early phase clinic.
The Joint Blog
APRIL 21, 2020
This is according to a study published in the Journal of Clinical Medicine Research and epublished by the U.S. For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. National Institute of Health.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Project CBD
NOVEMBER 11, 2023
He is the author of several bestselling books, including Spontaneous Healing (1995), Eating Well for Optimum Health (2000), and Healthy Aging (2007). So just on safety alone, it’s worth using it. His early publications ( The Natural Mind and From Chocolate to Morphine ) focused on exploring altered states of consciousness.
The Blunt Truth
AUGUST 13, 2019
On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. The public hearing attracted over 100 speakers and 2000 participants. 726) in March of 2019.
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.
Puff Puff Post
DECEMBER 28, 2018
With so many people affected by autism and incidence rates having increased by 119% between the years 2000 to 2010, it has gained the status of the quickest-growing developmental disability. The study also concludes that more clinical trials are required to take place before an accurate assessment on the use of cbd oil for autism can be made.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Articles were sourced from the start of 2000 to the end of 2019. Data collection.
Expert insights. Personalized for you.
75 
Let's personalize your content